Pages that link to "Q53591364"
Jump to navigation
Jump to search
The following pages link to Erythropoietin in the management of patients with nonhematologic cancer receiving chemotherapy. Systemic Treatment Program Committee. (Q53591364):
Displaying 5 items.
- Evaluating the role of quality assessment of primary studies in systematic reviews of cancer practice guidelines (Q24799623) (← links)
- Drug-induced myelosuppression : diagnosis and management (Q33349004) (← links)
- Onco-nephrology: an appraisal of the cancer and chronic kidney disease links (Q36801561) (← links)
- The pharmacokinetic profile of recombinant human erythropoietin is unchanged in patients undergoing cardiac surgery. (Q40031891) (← links)
- A multi-center open-labeled study of recombinant erythropoietin-beta in the treatment of anemic patients with multiple myeloma, low-grade non-Hodgkin's lymphoma, or chronic lymphocytic leukemia in Chinese population (Q51693538) (← links)